[go: up one dir, main page]

FI885930A - Förfarande för framställning av som läkemedel användbara 2-(aminoalkyltio)metyl-1,4-dihydropyridiner - Google Patents

Förfarande för framställning av som läkemedel användbara 2-(aminoalkyltio)metyl-1,4-dihydropyridiner Download PDF

Info

Publication number
FI885930A
FI885930A FI885930A FI885930A FI885930A FI 885930 A FI885930 A FI 885930A FI 885930 A FI885930 A FI 885930A FI 885930 A FI885930 A FI 885930A FI 885930 A FI885930 A FI 885930A
Authority
FI
Finland
Prior art keywords
aminoalkylthio
drug
methyl
preparation
dihydropyridines
Prior art date
Application number
FI885930A
Other languages
English (en)
Finnish (fi)
Other versions
FI91149C (sv
FI91149B (sv
Inventor
Carmelo Gandolfi
Marco Frigerio
Silvano Spinelli
Odoardo Tofanetti
Sergio Tognella
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Publication of FI885930A publication Critical patent/FI885930A/sv
Application granted granted Critical
Publication of FI91149B publication Critical patent/FI91149B/sv
Publication of FI91149C publication Critical patent/FI91149C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI885930A 1986-06-27 1988-12-21 Förfarande för framställning av som läkemedel användbara 2-(aminoalkyltio)metyl-1,4-dihydropyridiner FI91149C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT2096586 1986-06-27
IT20965/86A IT1204421B (it) 1986-06-27 1986-06-27 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
EP8700335 1987-06-25
PCT/EP1987/000335 WO1988000187A1 (en) 1986-06-27 1987-06-25 2-(aminoalkylthio)methyl-1,4-dihydropyridine, a method for the preparation thereof and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI885930A true FI885930A (sv) 1988-12-21
FI91149B FI91149B (sv) 1994-02-15
FI91149C FI91149C (sv) 1994-05-25

Family

ID=11174716

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885930A FI91149C (sv) 1986-06-27 1988-12-21 Förfarande för framställning av som läkemedel användbara 2-(aminoalkyltio)metyl-1,4-dihydropyridiner

Country Status (19)

Country Link
US (1) US5047414A (sv)
EP (2) EP0312541B1 (sv)
JP (1) JPH0832686B2 (sv)
KR (1) KR950002154B1 (sv)
AU (1) AU603595B2 (sv)
CA (1) CA1322753C (sv)
DK (1) DK164051C (sv)
ES (1) ES2037029T3 (sv)
FI (1) FI91149C (sv)
GR (1) GR3004954T3 (sv)
HU (1) HU201305B (sv)
IT (1) IT1204421B (sv)
MX (1) MX7134A (sv)
NZ (1) NZ220868A (sv)
PH (1) PH23208A (sv)
PL (1) PL156170B1 (sv)
RU (1) RU1816282C (sv)
WO (1) WO1988000187A1 (sv)
ZA (1) ZA874636B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
PL140573B1 (en) * 1982-12-21 1987-05-30 Pfizer Method of obtaining new dihydropyridine derivatives
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GR851819B (sv) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
KR930011486B1 (ko) * 1985-08-06 1993-12-08 베링거 만하임 이탈리아 에스.피.에이. 제약상 유효한 2-티오메틸-치환-1,4-디히드로피리딘

Also Published As

Publication number Publication date
WO1988000187A1 (en) 1988-01-14
PL266481A1 (en) 1988-09-01
CA1322753C (en) 1993-10-05
EP0312541B1 (en) 1992-08-26
IT1204421B (it) 1989-03-01
AU603595B2 (en) 1990-11-22
FI91149C (sv) 1994-05-25
KR880701228A (ko) 1988-07-26
HU201305B (en) 1990-10-28
EP0254064A1 (en) 1988-01-27
ES2037029T3 (es) 1993-06-16
DK99588D0 (da) 1988-02-25
EP0312541A1 (en) 1989-04-26
IT8620965A0 (it) 1986-06-27
DK164051B (da) 1992-05-04
KR950002154B1 (ko) 1995-03-14
RU1816282C (ru) 1993-05-15
MX7134A (es) 1993-10-01
PL156170B1 (pl) 1992-02-28
ZA874636B (en) 1988-03-30
NZ220868A (en) 1989-10-27
JPH0832686B2 (ja) 1996-03-29
AU7696987A (en) 1988-01-29
FI91149B (sv) 1994-02-15
PH23208A (en) 1989-06-06
DK164051C (da) 1992-09-28
US5047414A (en) 1991-09-10
JPH01503065A (ja) 1989-10-19
DK99588A (da) 1988-02-25
EP0254064B1 (en) 1992-06-17
GR3004954T3 (sv) 1993-04-28
HUT49572A (en) 1989-10-30

Similar Documents

Publication Publication Date Title
FI871492A0 (sv) Förfarande för framställning av som läkemedel användningsbara 2-tiometylsubstituerade 1,4-dihydropyridiner
FI881978A0 (sv) Förfarande för framställning av en farmaceutisk sammansättning, som innehåller eperison
FI891021A0 (sv) Förfarande för framställning av som läkemedel användbara 1,2,4-triazolderivat
FI98196B (sv) Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion
FI871294A0 (sv) Förfarande för framställning av som läkemedel användbara derivat av milbemycin
FI881103A (sv) Förfarande för framställning av som antidiabetiskt användbara benzoxazolderivat
FI103050B1 (sv) Förfarande för framställning av en komposition som innehåller N,O-sulfaterade heparosaner
NO874347D0 (no) Fremgangsmaate for fremstilling av insulin.
FI874020A0 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FI882099A (fi) Foerfarande foer bedoevning av slaktdjur, som andas med lungor.
FI872897A (fi) Nya 4-pyridonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI93107B (sv) Förfarande för framställning av som läkemedel användbara 2-imino-6-polyfluoralkoxibenzotiazolderivat
AR243185A1 (es) Procedimiento de preparacion de nuevas 1,4-dihidropiridinas utiles como medicamentos antitromboticos.
FI92387B (sv) Förfarande för framställning av en 3,4-difluorsubstituerad bensen
FI891257A (fi) Foerfarande och anordning foer framstaellning av marinbyggnadskonstruktioner, saosom bropelare, bryggor och liknande.
FI870293A0 (fi) 8 -acylaminoergoliner, deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
FI91149C (sv) Förfarande för framställning av som läkemedel användbara 2-(aminoalkyltio)metyl-1,4-dihydropyridiner
FI900129A0 (sv) Förfarande för framställning av 2-(N-fenylacetylaminopiperidin)-2,6-dion
FI873566A0 (fi) Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem.
FI891068A0 (sv) Förfarande för framställning av 3-(o-metoxifenoxi)-1,2-propandiol-1-karbamat
IT1206792B (it) Procedimento per preparare una mercaptoacilprolina.
FI890326A0 (sv) Förfarande för framställning av en torr, snabblöslig komposition av ett -laktamantibiotikum
FI871479A (sv) Förfarande för framställning av derivat av perhydrotiazepin och perhydroazepin, som är användbara som läkemedel
FI102370B1 (sv) Förfarande för framställnig av N-metyl-3,4-dimetoxifenyletylamin
NO870889L (no) FremgangsmŸte for fremstilling av aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BOEHRINGER MANNHEIM ITALIA S.P.A.